Two Brothers Leverage AI to Build $1.8 Billion Telehealth Empire from Scratch

By Tech News Desk | April 3, 2026

In a groundbreaking example of artificial intelligence reshaping entrepreneurship, two brothers from Los Angeles have constructed a $1.8 billion company with minimal resources, no traditional employees, and a heavy reliance on AI tools. Matthew Gallagher, 41, and his brother launched Medvi, a telehealth provider specializing in GLP-1 weight-loss drugs, using just $20,000 and a suite of AI technologies in a mere two months.[1][3]

Medvi burst onto the scene in September 2024, entering a competitive market dominated by players like Hims and Ro. What began with 300 customers in its first month exploded to 1,000 more the following month. By the end of 2025, the company’s first full year, Medvi had generated $401 million in sales, serving 250,000 customers and achieving a remarkable 16.2% net profit margin—equating to $65 million. This outperforms competitors like Hims, which reported only 5.5% net profit in the same period.[1][3][4]

AI as the Sole Workforce

The Gallagher brothers’ operation stands out for its lean structure: zero employees beyond themselves. Matthew Gallagher, a self-taught entrepreneur, harnessed over a dozen AI tools—including ChatGPT, Claude, and Grok—to handle every aspect of the business. From coding the platform’s software and crafting website copy to generating ad images, videos, and even managing customer service, AI did it all.[1][3]

Gallagher also developed custom AI systems for real-time business performance analysis, enabling data-driven decisions without a dedicated analytics team. “Growth was insane from the beginning,” Gallagher reportedly said, underscoring the rapid scalability AI afforded.[1]

Strategic Partnerships Over Infrastructure

Rather than investing in medical infrastructure, the brothers smartly outsourced core operations to established partners like CareValidate and OpenLoop Health. These alliances managed doctors, pharmacies, shipping, and regulatory compliance, allowing the Gallaghers to focus exclusively on branding, marketing, and customer acquisition.[1]

Medvi’s pricing strategy—$179 for the first month’s supply of GLP-1 drugs—positions it competitively in a market fueled by high demand for weight-loss solutions. Customers, described in some discussions as “desperate” for these drugs, have driven explosive growth.[4]

A Vision Echoing Silicon Valley Prophecies

This achievement aligns with predictions from figures like OpenAI’s Sam Altman, who foresaw one-person billion-dollar companies enabled by AI. Gallagher’s story proves the concept in practice, blending strategic sector selection (weight-loss telehealth) with AI automation.[1]

“A self-taught entrepreneur from Los Angeles has done what many in Silicon Valley said was coming but few expected to see so soon, building a billion-dollar company essentially alone.”[1]

Projections indicate Medvi is on track for $1.8 billion in revenue by the end of 2026, solidifying its status as an AI-driven unicorn. Expenses remain low, primarily covering telehealth platform fees, marketing, and software—demonstrating the cost efficiencies of AI.[1][4]

Broader Implications for Entrepreneurship

The Medvi saga challenges conventional startup wisdom, which typically demands large teams, venture capital, and years of development. Here, two individuals disrupted a high-stakes health sector by leveraging existing infrastructure and cutting-edge AI. Discussions on platforms like Hacker News highlight the model: choose a desperate market, build a simple interface, and let AI scale.[4]

Critics might point to the outsourced model as less innovative, but the results speak volumes. Medvi’s profitability—far exceeding peers—validates the approach. As AI tools evolve, expect more solo or micro-team ventures to emerge, potentially flooding niche markets.[2]

The Human Element Behind the AI

While AI powered the backend, the brothers’ vision was key. Matthew’s decision to target GLP-1 drugs—a class including semaglutide (Ozempic’s active ingredient)—tapped into surging demand amid global obesity concerns. Their LA home base served as headquarters, minimizing overhead.[3]

Industry watchers anticipate regulatory scrutiny as telehealth expands, but Medvi’s compliance partnerships mitigate risks. The story resonates beyond business: it democratizes success, showing that with AI, barriers to entry plummet.[2][3]

Future Outlook

With 2026 projections soaring, Medvi eyes further expansion. Gallagher’s blueprint—AI automation plus smart outsourcing—could inspire a wave of micro-entrepreneurs. As one observer noted, this is “what Silicon Valley predicted, but faster than anyone thought.”[1]

This tale of two brothers and their AI army redefines the billionaire startup playbook, proving that in the age of intelligent machines, solo ambition can yield empire-scale results.